What is Vascular Dynamics?
Vascular Dynamics is a pioneering medical technology firm focused on the development of innovative endovascular solutions. Its flagship MobiusHD technology represents a significant advancement in the field, serving as the first endovascular device designed to utilize the body's natural baroreflex mechanism. By modulating the autonomic nervous system to restore sympathetic balance, the company addresses critical physiological imbalances that contribute to severe health risks. This unique approach positions Vascular Dynamics at the intersection of interventional cardiology and neurology, providing a novel therapeutic pathway for patients who have exhausted traditional treatment options.
How much funding has Vascular Dynamics raised?
Vascular Dynamics has raised a total of $55.8M across 4 funding rounds:
Series A
$8.6M
Series B
$16.8M
Series C
$10.4M
Other Financing Round
$20M
Series A (2012): $8.6M, investors not publicly disclosed
Series B (2014): $16.8M led by MedFocus Fund, LLC, Rainbow Medical, and HBM Healthcare Investments
Series C (2017): $10.4M, investors not publicly disclosed
Other Financing Round (2022): $20M featuring Invus, Rainbow Medical, and HBM Healthcare Investments
Key Investors in Vascular Dynamics
Invus
Invus Group is an investment firm specializing in financial advice, investment services, and consulting services with a focus on long-term value creation.
Rainbow Medical
Rainbow Medical is a private operational investment company that invents and grows startup companies, developing breakthrough medical devices for diverse unmet medical needs.
HBM Healthcare Investments
HBM Healthcare Investments is a publicly traded investment company focused on the global healthcare sector, with a diversified portfolio of private and publicly listed companies.
What's next for Vascular Dynamics?
With the recent capital injection, Vascular Dynamics is poised to transition from clinical evaluation to broader market integration. The strategic focus will likely center on finalizing clinical data sets to support regulatory milestones and scaling the manufacturing of the MobiusHD platform. As the company navigates the complexities of the healthcare landscape, the continued support from specialized life sciences investors will be instrumental in driving commercialization efforts. Future growth will be dictated by the firm's ability to demonstrate long-term clinical efficacy and secure widespread adoption among interventional specialists seeking to improve patient outcomes in autonomic-related pathologies.
See full Vascular Dynamics company page
